News Agency
Men's Weekly

Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting

  • Written by PR Newswire

SHANGHAI, June 3, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company, announced today that the preliminary Phase 1/2 clinical data of MHB088C (B7-H3 ADC) was presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in an oral presentation.

Abstract #: 3012

Results of a Phase...

Read more: Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for...

Why Defence Recruitment Plays A Key Role In Supporting The Defence Industry

The defence sector is a vital part of national security and technological development. It supports military operations, research programs, and strategic planning that help protect national interests. As the defence sector continues to evolve, organisations rely on specialised hiring processes... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion